The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

4 Aug 2011 07:00

RNS Number : 7064L
China Growth Opportunities Ltd
04 August 2011
 



CHINA GROWTH OPPORTUNITIES LIMITED

 

RESULTS FOR THE YEAR ENDED 31 MARCH 2011

 

 

KEY POINTS

 

·; Return of capital to Ordinary Shareholders of £3million for the year (6p per Ordinary Share).

·; In specie distribution to Ordinary Shareholders of the majority of the Company's holding in China CDM Exchange Centre at the start of August 2011.

·; Net assets at 31 March 2011 of £1.8 million (2010: £6.3 million).

·; Net assets per share at 31 March 2011 of 3.55p (2010: 12.52p).

·; Sale of holdings in China Metal Packaging and Dalian Business Institute and partial sale of the holding in China CDM Exchange Centre during the year ended 31 March 2011 for £3.8 million.

 

The 2011 Annual Financial Report & Accounts are being sent to Shareholders and will be available shortly on the Company's website: www.chinagrowthopportunities.com. Copies can be obtained in hard copy form free of charge, from the Company Secretary, Elysium Fund Management Limited, PO Box 650, 2nd Floor, No. 1 Le Truchot, St Peter Port, Guernsey, GY1 3JX.

 

For further information please visit www.chinagrowthopportunities.com or contact:

 

Rhys Davies

Chairman

Tel: +41 79 620 0215

James Maxwell

Singer Capital Markets Limited

Tel: +44 20 3205 7623

Elysium Fund Management Limited

PO Box 650

No. 1 Le Truchot

St Peter Port

Guernsey

GY1 3JX

 

Tel: +44 1481 810 100

Fax: +44 1481 810 120

e-mail: Elysium@elysiumfundman.com

 

 

 

 

CHAIRMAN'S STATEMENT

 

I am pleased to have the opportunity to present the results of China Growth Opportunities Limited (the "Company") for the year ended 31 March 2011.

 

Results

The net asset value of the Company at 31 March 2011 was £1.8 million (2010: £6.3 million), equal to 3.55p per Ordinary Share (2010: 12.52p per Ordinary Share). The 72% decrease in net asset value from 31 March 2010 was due to the £3.0 million return of capital to shareholders and the £1.5 million net loss for the year under review (2010: loss £9.3 million), representing a loss per Ordinary Share of 2.97p (2010: loss of 18.52p), which arose primarily from the downwards revaluation of the Company's investments in China CDM Exchange Centre Limited ("CCEC") and Wan Wei Oil & Gas Technology ("Wan Wei").

 

Investing Policy

The Investing Policy of the Company is to manage the sale of the Company's investment portfolio and to maximise the return of invested capital to shareholders during the period ending on 30 September 2011. It is proposed to extend this policy for a further 12 months to allow the Directors time to attempt to realise value from CCEC and Wan Wei.

 

Return of Capital

On 31 January 2011 the Company made a return of capital to shareholders of 6.00p per Ordinary Share (equivalent to £3.0 million). On 8 June 2011, the Board announced that the Company would pay a further return of capital of 1.50p per Ordinary Share to shareholders on 6 July 2011.

 

We have actively sought to dispose of the Company's holding in China CDM Exchange Centre Limited ("CCEC"). Since November 2010, all efforts to seek trade, corporate or investment buyers have been unsuccessful. Therefore, the Board attempted to distribute the majority of the Company's holding in CCEC to the Company's shareholders. However, the management of CCEC refused to sanction the transfer of shares, which was in breach of PLUS Rule 3, and as a result, on 24 March 2011, CCEC was suspended from trading on PLUS. This transfer was recently resolved, and, on 28 July 2010, the Company announced that it was to distribute 9,364,963 shares in CCEC by way of a distribution in specie to shareholders in the Company. Accordingly, 9,364,963 shares in CCEC, being the bulk of the Company's holding, have been transferred to shareholders in the Company who were on the register as at 5 p.m. on 4 July 2011. Shareholders will have received 0.1873 CCEC shares for every 1 China Growth Opportunities Limited Ordinary Share held. Based on the mid-market price per CCEC share of 3.5p as at close of business on 27 July 2011, this return of capital is equal to approximately 0.65 pence per China Growth Opportunities Limited Ordinary Share. Given that the transfer has now taken place, we expect CCEC's suspension from trading on PLUS to be lifted shortly.

 

Fractional entitlements were not issued to the Company's shareholders and all fractional entitlements to which holders of the Company's shareholders would have become entitled were rounded down and retained by the Company. The Company has retained 4,937 shares in CCEC as a result of these fractional entitlements.

 

We will continue to try to dispose of the remaining investments and return funds to shareholders. Any further returns of capital will be at the discretion of the Board and will be subject to the rate at which the Company's investments are realised and the Company's financial position at the time.

 

Investments

During the year ended 31 March 2011, the Company sold its entire holding in China Metal Packaging Group Company Limited ("CMP") back to CMP for US$6 million (£3.8 million) and, as a result of the sale, Brett Miller stepped down from CMP's board of directors. In addition, during the year, the Company sold its entire holding in Dalian Business Institute Limited for US$10,000 and 502,600 shares in CCEC for £77,000. The investment in China Real Estate Services Limited was liquidated but, as the liquidation costs were greater than the proceeds, no distribution was received.

 

The proceeds from the sale of these investments were £0.2 million below the 31 March 2010 "fair value" of these investments and a loss of £5.6 million compared to cost was realised on their disposal.

 

At 31 March 2011 the Company held three investments, which cost £7.7 million (31 March 2010: six investments which cost £17.1 million). At 31 March 2011, these investments had a fair value of £0.2 million (2010: £5.1 million).

 

The valuation of CCEC fell by 77% in the year under review. On 31 December 2010, a co-operation agreement expired between CCEC and a Chinese emissions broker. This Chinese emissions broker accounted for more than 60% of CCEC's revenue in 2010 and had previously subcontracted all services relating to all of its existing and future CDM projects to CCEC. A new co-operation agreement has not been signed and on 24 March 2011, CCEC was suspended from trading on PLUS, following a breach of PLUS Rule 3, but, as mentioned above, we expect CCEC's suspension from trading on PLUS to be lifted shortly.

 

On 9 July 2010, the Company agreed to sell its entire holding in Wan Wei for a total of US$750,000, which was due in three equal instalments in September 2010, December 2010 and March 2011. The company did not receive any of the instalments and the sale did not proceed. Although the convertible loan note is due in May 2012, the Directors do not believe that Wan Wei will be in a position to redeem the loan note on even a partial basis. As the result of bad debt problems, Wan Wei lacks sufficient working capital to advance the business and at 28 February 2011, had less than US$130,000 in gross cash balances. On the basis of the aborted sale and the likely inability of Wan Wei to even partially redeem the convertible loan note given its financial position, we have written-down the value of the Company's interest in Wan Wei to nil.

 

Our approach to the valuation of the Company's investments reflects our view of fair value being the value at which your investments could have been exchanged between knowledgeable, willing parties in an arm's length transaction at the reporting date.

 

Outlook

As a Board we are further reducing operating costs through service provider contract re-negotiations and other overhead reductions. Our objective is to realise assets at the appropriate time and value, and to return the proceeds less expenses to our shareholders. I am hopeful that there will be further progress to report in the near future.

 

Respectfully yours

R Davies

2 August 2011

 

 

 STATEMENT OF COMPREHENSIVE INCOME

for the year ended 31 March 2011

Year ended

31 March 2011

Year ended

31 March 2010

£'000

£'000

Investment gains and losses

Net unrealised change in fair value of investments

4,453

3,412

Realised loss from sale of investments

(5,565)

(11,303)

------------

------------

Total investment losses

(1,112)

(7,891)

Income

Other income

3

7

------------

------------

Total income

3

7

Expenses

Directors' remuneration

(117)

(179)

Administration fees

(119)

(170)

Other expenses

(141)

(395)

Investment Consultant's fee

-

(140)

------------

------------

Total expenses

(377)

(884)

Loss on foreign currency exchange

-

(491)

------------

------------

Loss for the year

(1,486)

(9,259)

Other comprehensive income

Exchange differences arising from translation of foreign operations

-

(2)

------------

------------

Total other comprehensive loss

-

(2)

------------

------------

Total comprehensive loss for the year attributable to the shareholders

 

(1,486)

 

(9,261)

------------

------------

Loss per Ordinary Share - basic and diluted

(2.97)p

(18.52)p

 

 

STATEMENT OF FINANCIAL POSITION

as at 31 March 2011

 

31 March 2011

31 March 2010

£'000

£'000

Non-current assets

Investments designated at fair value through profit or loss

187

5,146

----------

----------

Current assets

Other receivables

12

13

Cash and cash equivalents

1,652

1,212

----------

----------

1,664

1,225

----------

----------

Total assets

1,851

6,371

----------

----------

Current liabilities

Payables and accruals

(76)

(110)

----------

----------

Net assets

1,775

6,261

----------

----------

Capital and reserves attributable to equity holders of the Company

Share capital

500

500

Other reserve

2,293

2,293

Distributable reserves

(1,018)

3,468

----------

----------

Total equity shareholders' funds

1,775

6,261

----------

----------

Net Asset Value per Ordinary Share - basic and diluted

3.55p

12.52p

 

 

 STATEMENT OF CHANGES IN EQUITY

 

 

for the year ended 31 March 2011

 

 

 

 

Share capital

Other reserve

Distributable reserves

 

Total

£'000

£'000

£'000

£'000

Balance at 31 March 2010

500

2,293

3,468

6,261

Return of Capital

-

-

(3,000)

(3,000)

Total comprehensive loss for the year

Loss for the year

-

-

(1,486)

(1,486)

Other comprehensive loss

-

-

-

-

----------

----------

----------

----------

Balance at 31 March 2011

500

2,293

(1,018)

1,775

----------

----------

----------

----------

 

 

 

for the year ended 31 March 2010

 

 

 

 

Share capital

Other reserve

Distributable reserves

Foreign exchange translation reserve

 

Total

 

£'000

£'000

£'000

£'000

£'000

 

Balance at 31 March 2009

500

2,293

22,727

2

25,522

 

Return of Capital

-

-

(10,000)

-

(10,000)

 

Total comprehensive loss for the year

 

Loss for the year

-

-

(9,259)

-

(9,259)

 

Other comprehensive income

-

-

-

(2)

(2)

 

----------

----------

----------

----------

----------

 

Balance at 31 March 2010

500

2,293

3,468

-

6,261

 

----------

----------

----------

----------

----------

 

 

 

 STATEMENT OF CASH FLOWS

for the year ended 31 March 2011

Year ended

31 March 2011

Year ended

31 March 2010

£'000

£'000

Cash flows from operating activities

Other income received

3

8

Investment Consultant's fees paid

-

(220)

Administration fees paid

(125)

(170)

Directors' remuneration paid

(136)

(164)

Audit fees paid

(23)

(66)

Other expenses paid

(126)

(359)

----------

----------

Net cash outflow from operating activities

(407)

(971)

Cash flows from investing activities

Sale of investments designated at fair value through profit or loss

3,847

7,569

----------

----------

Net cash inflow from investing activities

3,847

7,569

Cash flows from financing activities

Return of capital

(3,000)

(10,000)

----------

----------

Net cash outflow from investing activities

(3,000)

(10,000)

----------

----------

----------

----------

Increase/(decrease) in cash and cash equivalents

440

(3,402)

----------

----------

Cash and cash equivalents brought forward

1,212

4,930

Increase/(decrease) in cash and cash equivalents

440

(3,402)

Foreign exchange movement

-

(316)

----------

----------

Cash and cash equivalents carried forward

1,652

1,212

----------

----------

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SSDFMDFFSEEA
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.